LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global autoinjectors market to grow at a CAGR of over 23% during the forecast period, according to their latest market research report. The ...

Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors may have limited effectiveness in helping patients survive anaphylaxis events, ...

The Autoinjectors Market is projected to grow at a rate of 14-16% by 2028, driven by the rising incidence of chronic and lifestyle diseases, growing patient preference for self-administration of ...

Novo Nordisk has spent the last two years scrambling to keep up with skyrocketing demand for its blockbuster GLP-1 drugs, the obesity-focused Wegovy and Type 2 diabetes med Ozempic, forcing it to ...

The FDA said nasal spray containing up to 4mg of naloxone and autoinjectors with a 2 mg dose might be safe for people to administer without a prescription. But the drug regulator stressed that it ...

Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...

Drug delivery opportunities are at the heart of Halozyme Therapeutics Inc.’s nearly $1 billion acquisition of Antares Pharma Inc. The deal brings Halozyme an autoinjector platform to complement its ...

Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors may have little effect on surviving anaphylaxis events. Research is needed in ...

The FDA is warning healthcare professionals about compatibility issues between autoinjectors and glatiramer acetate injections, which are approved to treat relapsing forms of multiple sclerosis. If ...